Literature DB >> 1903878

Evidence for widespread occurrence of antibodies to Encephalitozoon cuniculi (Microspora) in man provided by ELISA and other serological tests.

W S Hollister1, E U Canning, A Willcox.   

Abstract

The enzyme-linked immunosorbent assay (ELISA) was used to survey human sera for antibodies to Encephalitozoon cuniculi using spores obtained from in vitro cultures as antigen. Sera were obtained from patients with tropical diseases, neurological and renal disorders, patients who were HIV positive and those who had been tested for HIV but found to be negative. Sera from inhabitants of the village of Jali, The Gambia and from healthy blood donors were also examined. Numerous sera from all groups except the blood donors gave positive ELISA reactions at dilutions of 1:400. On titration, those with titres of 1:400 were reclassified as negative. Antibody titres of 1:800 and above were considered to be indicative of past or present infections with E. cuniculi. Many of these ELISA seropositives were also positive by IFAT or PAP. When examined by Western blotting of SDS-PAGE protein profiles of E. cuniculi spores, sera from many patients who had a tropical association reacted with the characteristic profiles shown by known positive mouse and rabbit sera. Others in the tropical group showed antibody binding to some but not all of the immunodominant polypeptides and yet others were negative in spite of their reactivity in the ELISA, IFAT or PAP test. Less agreement between ELISA and Western blotting results was obtained with the other groups of patients, although reactivity with one or more of the major polypeptide bands was sometimes seen. Serum from one blood donor, examined by ELISA and Western blotting, was positive. Differences in the methods of antigen preparation and of epitopes recognized by individuals may account for different reactivities in the tests. It is concluded that infections of E. cuniculi are common in the tropics and that reactivations of these infections might be a hazard to AIDS patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903878     DOI: 10.1017/s0031182000060315

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  17 in total

1.  Carbohydrate moieties of microsporidian polar tube proteins are targeted by immunoglobulin G in immunocompetent individuals.

Authors:  Ron Peek; Frédéric Delbac; Dave Speijer; Valérie Polonais; Sophie Greve; Ellen Wentink-Bonnema; Jeffrey Ringrose; Tom van Gool
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis.

Authors:  Hong Zhang; Huan Huang; Ann Cali; Peter M Takvorian; Xiaochuan Feng; Ghou Zhou; Louis M Weiss
Journal:  Folia Parasitol (Praha)       Date:  2005-05       Impact factor: 2.122

Review 3.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470.

Authors:  John Jeff Alvarado; Anjana Nemkal; J Michael Sauder; Marijane Russell; Donna E Akiyoshi; Wuxian Shi; Steven C Almo; Louis M Weiss
Journal:  Mol Biochem Parasitol       Date:  2009-08-04       Impact factor: 1.759

Review 5.  Waterborne protozoan pathogens.

Authors:  M M Marshall; D Naumovitz; Y Ortega; C R Sterling
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique.

Authors:  T van Gool; F Snijders; P Reiss; J K Eeftinck Schattenkerk; M A van den Bergh Weerman; J F Bartelsman; J J Bruins; E U Canning; J Dankert
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

7.  Comparison of three staining methods for detecting microsporidia in fluids.

Authors:  E S Didier; J M Orenstein; A Aldras; D Bertucci; L B Rogers; F A Janney
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

8.  In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi.

Authors:  B Beauvais; C Sarfati; S Challier; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 9.  Human microsporidial infections.

Authors:  R Weber; R T Bryan; D A Schwartz; R L Owen
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 10.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.